Search results
Wimbledon: Zverev beats injury and Norrie to make Round 4
rediff.com· 7 hours agoIMAGE: Germany's Alexander Zverev celebrates victory over Britain's Cameron Norrie in the third...
VP Jagdeep Dhankhar Takes Dig At P Chidambaram For Jibe On Criminal Laws
One India· 12 hours agoThe VP, who is also the Chairman of the Rajya Sabha, said that every MP had the opportunity to...
'Are We Part-Timers In Parliament?': Jagdeep Dhankhar Excoriates Chidambaram Over Remark Against New...
Times Now· 13 hours agoThiruvananthapuram: The Vice-President of India Jagdeep Dhankhar condemned the remarks by senior...
‘Derogatory, defamatory and highly insulting’: Vice-President Jagdeep Dhankhar on P Chidambaram’s...
Indian Express· 14 hours agoWhile addressing the 12th convocation of the Indian Institute of Space Science and Technology (IIST)...
Chronicling parliamentary proceedings over time
The Hindu· 2 days agoThe first session of the 18th Lok Sabha was also the first session when the Central Industrial Security Force (CISF) took over security of the Parliament...
Novak Djokovic Survives Rookie Test As Wimbledon Craves Andy Murray Magic | Tennis News
NDTV· 2 days agoNovak Djokovic came through a testing Wimbledon workout to stay on course for a record-equalling...
Wimbledon PIX: Zverev, Djokovic, Rune cruise through
rediff.com· 2 days agoIMAGE: Germany’s Alexander Zverev proved too strong for Marcos Giron of the United States to reach the Wimbledon third round, where he will face Briton...
T20 World Cup 2024: Dancin’ to the full house rock!
Mid Day· 3 days agoIndia captain Rohit Sharma holds the T20 World Cup trophy during the open bus victory parade at Marine Drive in Mumbai yesterday. Finally, the T20 World...
"A Nobody Like Me...": After Manipur Congress MP's Parliament Speech, BJP's "Core Issues" Jab
NDTV· 3 days agoMr Akoijam, who teaches at the Centre for the Study of Social Systems in Delhi's Jawaharlal Nehru...
Beacon secures $170m to advance ophthalmic gene therapies
Pharmaceutical Technology· 3 days agoFollowing on from this data, the first patient was enrolled in the pivotal Phase II/III VISTA...